Patents Assigned to PeronGen BioTherapeutics (Suzhou) Co., Ltd.
  • CD7 nanobodies, encoding sequence and use thereof
    Patent number: 10106609
    Abstract: Provided is a nanometer antibody for human CD7 molecule and an encoding DNA sequence thereof. The nanometer antibody can be efficiently expressed in Escherichia coli, and can be used for preparing an agent for the detection of CD7 molecule and targeted therapy.
    Type: Grant
    Filed: April 29, 2015
    Date of Patent: October 23, 2018
    Assignee: PeronGen BioTherapeutics (Suzhou) Co., Ltd.
    Inventors: Lin Yang, Jinle Tang